BeStock  

BioCryst Pharmaceuticals BCRX

US equityMarket cap rank #2750Drug Manufacturers - Specialty & Generic
$8.10 −$0.07 (-0.86%)
Pre-market · Oct 6, 7:30 am ET · After hours $8.10 0.00%
Open$8.17
Prev close$8.17
Day range$7.92 – $8.25
Volume4.71M
Market cap$2.07B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts7
Average target$19.57+141.6% vs. price
  • Buy 71%
  • Hold 29%
Low $11.00Now $8.10Avg $19.57High $32.00

Recent rating changes

The last 20 actions on file set price targets from $11.00 to $32.00, averaging $20.40.

DateFirmRatingTarget
30 Sep 2026 J.P. Morgan HOLD $13.00
10 Sep 2026 RBC Capital HOLD $11.00
8 Sep 2026 Needham BUY $16.00
6 Aug 2026 Wedbush BUY $20.00
6 Aug 2026 H.C. Wainwright BUY $32.00
5 Aug 2026 TD Cowen BUY $30.00
5 Aug 2026 Needham BUY $16.00
5 Aug 2026 RBC Capital BUY $13.00
15 Jul 2026 BofA Securities BUY $15.00
13 Jul 2026 Wedbush BUY $21.00
13 Jul 2026 J.P. Morgan HOLD $12.00
7 Jul 2026 RBC Capital BUY $14.00
30 Jun 2026 Cantor Fitzgerald BUY $29.00
30 Jun 2026 Wedbush BUY $21.00
30 Jun 2026 Needham BUY $16.00
30 Jun 2026 H.C. Wainwright BUY $32.00
29 Jun 2026 Needham BUY $16.00
7 May 2026 Wedbush BUY $21.00
7 May 2026 Citizens JMP BUY $28.00
7 May 2026 H.C. Wainwright BUY $32.00

Discussion

No comments yet — be the first to weigh in on BCRX.

Leave a comment

Scroll to Top